Where does GlySens Incorporated rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), GlySens Incorporated ranks #31,785 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does GlySens Incorporated hold?

GlySens Incorporated holds 8 US utility patents granted between 2020 and 2022, spanning 9 technology areas.

What is GlySens Incorporated's Innovation Score?

GlySens Incorporated has an Innovation Score of 35.4 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does GlySens Incorporated focus on?

GlySens Incorporated's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 8 patents, ranking #2,086 of 7,127 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is GlySens Incorporated's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for GlySens Incorporated.

What does claim depth mean for GlySens Incorporated's patents?

GlySens Incorporated's patents average 29.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the GlySens Incorporated patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

GlySens Incorporated

USPTO PatentsView assignee record - 8 granted patents across 9 technology areas, recorded in grant years 2020–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Glysens ranks #31,785 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 9 technology areas.

#31,785
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.4/100): 29.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R31785 · US Corporation #31,785 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 8 grants
MID-PACK #31,785/49,997
PHOTO-FINISH GlaxoSmithKline…
CPC-NARROW A61B · 9 areas
INNOV-THIN 35.4/100
CLAIMS-DENSE 29.1 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2022 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: GlaxoSmithKline Consumer Healthcare GmbH and Co. KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Glysens’s 35.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (21%) Velocity 2.2 pts (6%) Breadth 10.6 pts (30%) Claim depth 15.0 pts (42%)

Qualcomm Incorporated · highest

85
GlySens Incorporated · this assignee

35
3D Lighting… · lowest

7

What this shows Glysens's Innovation Score is 35.4/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Glysens?

Each dot is one of Glysens’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Glysens’s own 29.1 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Glysens vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Glysens's grants concentrate

GlySens Incorporated is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (6 grants) versus a trough of 2 in 2022. By volume, Glysens sits between GlaxoSmithKline Consumer Healthcare GmbH and Co. KG and GoKnown LLC.

Glysens's three-year grant acceleration

GlySens Incorporated shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Glaxosmithkline C…

8
Glean

8
Global Algae Tech…

8
Global Energy Sci…

8
Go Papa Lllp

8
Go Team CCR

8
Gofire

8
Goknown

8
Glysens Incorpora… ◀

8

What this shows GlySens holds 8 patents at rank #31,816, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near GlySens

By rank, the assignees closest to #31,816 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in GlySens's primary technology class.

Glysens's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

GlySens Incorporated patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	6	75.0%
2022	2	25.0%

Which technologies does GlySens Incorporated patent most?

A61B - DIAGNOSIS; SURGERY; Identification 8

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

G06N - Computing Arrangements Based ON Specific Computational Models 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Y10T - Technical Subjects Covered BY Former US Classification 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

GlySens Incorporated's patent record in context - here's where to go next.

GlySens Incorporated's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #31,785 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare GlySens Incorporated against GlaxoSmithKline Consumer Healthcare GmbH and Co. KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.